Newswise — Chicago, Illinois: The Hematology/Oncology Pharmacy Association has elected Dr. Scott Soefje, PharmD MBA BCOP FCCP to serve as President for the 2015-2016 term. Soefje recently took office at the 11th HOPA Annual Conference held March 25-28, in Austin, Texas. Soefje has served as President-elect since March of 2014.
“Scott’s career is filled with numerous milestones and contributions to the field of hematology/oncology pharmacy. His 20 years of dedication and active involvement in education, research, advocacy, and professional development is remarkable. Scott has had steady involvement with HOPA in various leadership roles, all of which have provided rich opportunities and impact in helping to define and advance our association,” states Michael Vozniak PharmD BCOP, immediate HOPA past president, in making the announcement.
Soefje is a founding member of HOPA, with volunteer contributions that have extended to nearly every facet of the association’s governance, including At Large Member of the Board from 2012 -2014. Most recently, he has been an adviser to the Professional Development committee and member of the Leadership task force which is setting the direction for leadership development of members within the organization as well as in their professional settings. He has also chaired the Health Policy and Advocacy Committee from 2008-2011.
Currently, Soefje serves as the Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. He earned a Bachelor’s Degree in Pharmacy from University of Texas (UT) Austin, a PharmD from the combined program at The UT Health Science Center San Antonio and UT Austin, and an MBA from George Washington University. His oncology pharmacy residency was at the Audie L. Murphy Veterans Hospital in San Antonio and clinical pharmacology fellowship was at M. D. Anderson Cancer Center in Houston. He has been board certified since 2000. Soefje's interest in oncology is driven by pharmacology and the impact that pharmacy can have on cancer patients.
The Hematology/Oncology Pharmacy Association (HOPA) is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has more than 2300 members and includes oncology pharmacists, as well as pharmacy interns, residents, nurses, technicians, researchers, and administrators specializing in hematology/oncology practice. To learn more about HOPA, visit www.hoparx.org.